Kale Asset Holding Ltd Reduces Stake in LUYE PHARMA (02186) by 11.25 Million Shares at Average Price of HKD 3.76 Per Share

Stock News

Aug 22

According to the latest data from the Hong Kong Stock Exchange, on August 13, Kale Asset Holding Ltd reduced its holdings in LUYE PHARMA (02186) by 11.246 million shares at an average price of HKD 3.763 per share, with a total transaction value of approximately HKD 42.32 million. Following this reduction, the latest shareholding stands at approximately 300 million shares, representing a 7.93% stake in the company. The transaction involved other related parties including Ong Tiong Sin, RRJ Capital IV Ltd, and RRJ Capital Master Fund IV, L.P.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1165611721"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1165611721\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1165611721?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-22 19:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165611721","market":"us","top_or_hot":-1,"title":"Kale Asset Holding Ltd Reduces Stake in LUYE PHARMA (02186) by 11.25 Million Shares at Average Price of HKD 3.76 Per Share","media":"Stock News","content":"<p>According to the latest data from the Hong Kong Stock Exchange, on August 13, Kale Asset Holding Ltd reduced its holdings in LUYE PHARMA (02186) by 11.246 million shares at an average price of HKD 3.763 per share, with a total transaction value of approximately HKD 42.32 million. Following this reduction, the latest shareholding stands at approximately 300 million shares, representing a 7.93% stake in the company. The transaction involved other related parties including Ong Tiong Sin, RRJ Capital IV Ltd, and RRJ Capital Master Fund IV, L.P.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kale Asset Holding Ltd Reduces Stake in LUYE PHARMA (02186) by 11.25 Million Shares at Average Price of HKD 3.76 Per Share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKale Asset Holding Ltd Reduces Stake in LUYE PHARMA (02186) by 11.25 Million Shares at Average Price of HKD 3.76 Per Share\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-08-22 19:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to the latest data from the Hong Kong Stock Exchange, on August 13, Kale Asset Holding Ltd reduced its holdings in LUYE PHARMA (02186) by 11.246 million shares at an average price of HKD 3.763 per share, with a total transaction value of approximately HKD 42.32 million. Following this reduction, the latest shareholding stands at approximately 300 million shares, representing a 7.93% stake in the company. The transaction involved other related parties including Ong Tiong Sin, RRJ Capital IV Ltd, and RRJ Capital Master Fund IV, L.P.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1606","symbol_name":"中医药概念","start_time":0,"source_url":"","article_id":"1165611721","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165611721","pubTimestamp":1755863538,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"According to the latest data from the Hong Kong Stock Exchange, on August 13, Kale Asset Holding Ltd reduced its holdings in LUYE PHARMA (02186) by 11.246 million shares at an average price of HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1606":"中医药概念","02186":"绿叶制药","BK1583":"高瓴概念","BK1191":"制药"},"translate_title":"Kale Asset Holding Ltd减持绿叶制药(02186)1125万股每股均价3.76港元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02186":1},"content_text":"According to the latest data from the Hong Kong Stock Exchange, on August 13, Kale Asset Holding Ltd reduced its holdings in LUYE PHARMA (02186) by 11.246 million shares at an average price of HKD 3.763 per share, with a total transaction value of approximately HKD 42.32 million. Following this reduction, the latest shareholding stands at approximately 300 million shares, representing a 7.93% stake in the company. The transaction involved other related parties including Ong Tiong Sin, RRJ Capital IV Ltd, and RRJ Capital Master Fund IV, L.P.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}